drugset / Trial / NCT00893217
BEYOND Pilot Study
RandomizedParallel-groupDouble-blindTreatment
Summary
The purpose of this study is to valuate safety and tolerability of Betaseron.
Timeline
- Start
- 2002-11
- Primary completion
- —
- Completion
- 2003-06
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Interferon beta-1b | Protein / enzyme biologic | 250 ug | Subcutaneous |
| Subject | Interferon beta-1b | Protein / enzyme biologic | 500 ug | Subcutaneous |